Colgate-Palmolive (CL) Remains Overweight as JPMorgan Sees Headwinds Easing in 2026
On December 18, JPMorgan raised its price target on Colgate-Palmolive Company (NYSE:CL) to $88 from $87 and kept an Overweight rating as part of its 2026 outlook.
Colgate Palmolive Co (CL)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | GQG Partners Rajiv Jain | 11,365,410 | $908,551,381 | -21% | 1.4% |
| 2. | Diamond Hill Capital Ric Dillon | 8,077,549 | $645,719,267 | +47% | 3.07% |
| 3. | First Eagle Investment Management Jean-Marie Eveillard | 7,889,103 | $630,654,929 | +1% | 1.15% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 5,358,971 | $428,396,142 | -19% | 0.27% |
| 5. | GuardCap Asset Management Guardian Capital | 3,515,478 | $281,027,311 | -10% | 6.51% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $80.89 | 1,237 | $100,060.93 | 13,751 | 2025-11-21 | Filing | |
| $88.97 | 2,250 | $200,182.73 | 12,583 | 2025-05-15 | Filing | |
| $92.02 | 8,000 | $736,152.00 | 14,805 | 2025-02-25 | Filing | |
| $95.94 | 1,054 | $101,120.76 | 9,620 | 2024-11-26 | Filing | |
| $95.00 | 33,333 | $3,166,635.00 | 270,689 | 2024-11-22 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,286,644 | $101,670,581 | 1.52% | |
| 2. | 23,329 | $1,843,458 | 0.09% | |
| 3. | 17,012 | $1,344,288 | 0.81% | |
| 4. | 14,362 | $1,134,885 | 0.04% | |
| 5. | 13,140 | $1,038,322 | 0.1% |
News See All
13 Best January Dividend Stocks to Invest In
Valuations have climbed to historically high levels as tech stocks stayed in favor.
Colgate-Palmolive (CL) Target Raised as Analysts Split on 2026 Staples Outlook
On December 19, BofA raised its price target on Colgate-Palmolive Company (NYSE:CL) to $90 from $88 and kept a Buy rating.
14 Best Dividend Aristocrats to Invest in Heading into 2026
A clear example is the S&P 500 Dividend Aristocrats Index, which tracks companies that have raised their dividends every year for at least 25 years.
Margin Headwinds Prompt Argus to Downgrade Colgate (CL) Shares
On December 11, Argus analyst Taylor Conrad downgraded Colgate-Palmolive Company (NYSE:CL) to Hold from Buy, citing mounting pressures on the company’s profitability.
15 Best Blue-Chip Stocks with Growing Dividends
Dividend stocks have fallen behind the broader market this year as investors have piled into tech and AI names. Still, that doesn’t take away from their long-term value.
Colgate-Palmolive (CL) Rated Outperform by RBC as Long-Term Growth Remains in Focus
On December 9, RBC Capital raised its rating on Colgate-Palmolive Company (NYSE:CL) to Outperform from Sector Perform while keeping the price target at $88.
15 Best Stocks to Buy for the Long Term
Dividend stocks offer solid investment options when it comes to long-term investing.
Analysts Highlight Colgate-Palmolive’s Efforts to Drive Category Growth
On November 4, Barclays cut its price target on Colgate-Palmolive Company (NYSE:CL) to $80 from $82 while maintaining an Equal Weight rating after the company’s latest earnings...
15 Best Boring Dividend Stocks to Buy
Investing in high-quality dividend growth stocks may not seem very exciting.
Hedge Fund Resource Center Billionaire Hedge Funds
